Neurological effects of encapsulated dexamethasone sodium phosphate in children aged 6-9 years with ataxia telangiectasia (NEAT): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Russo S, Zielen S, Pietrucha B, Trischler J, Perlman S, Zielonka D, Del Mar Garcia Romero M, Ip W, Stray-Pedersen A, Børresen ML, Gomez-Andres D, Lissauer S, Pachlopnik-Schmid J, Karampatsas K, Wu S, Pisani F, Lederman H, Badolato R, Kern J, Kornmann O, Donath H, Whitehouse WP, Koenig MK, Abolhassani H, Schaefer C, Roden M, Thye D, Smith A, Horn B, Prayle A

Open source

DOI
10.1016/s2352-4642(26)00125-2
Published
2026 Oct
Container
The Lancet. Child & adolescent health
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2352-4642-26-00125-2,
  title = {Neurological effects of encapsulated dexamethasone sodium phosphate in children aged 6-9 years with ataxia telangiectasia (NEAT): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.},
  author = {Russo S and Zielen S and Pietrucha B and Trischler J and Perlman S and Zielonka D and Del Mar Garcia Romero M and Ip W and Stray-Pedersen A and Børresen ML and Gomez-Andres D and Lissauer S and Pachlopnik-Schmid J and Karampatsas K and Wu S and Pisani F and Lederman H and Badolato R and Kern J and Kornmann O and Donath H and Whitehouse WP and Koenig MK and Abolhassani H and Schaefer C and Roden M and Thye D and Smith A and Horn B and Prayle A},
  year = {2026},
  journal = {The Lancet. Child \& adolescent health},
  doi = {10.1016/s2352-4642(26)00125-2},
  url = {https://doi.org/10.1016/s2352-4642(26)00125-2}
}

RIS

TY  - JOUR
TI  - Neurological effects of encapsulated dexamethasone sodium phosphate in children aged 6-9 years with ataxia telangiectasia (NEAT): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
AU  - Russo S
AU  - Zielen S
AU  - Pietrucha B
AU  - Trischler J
AU  - Perlman S
AU  - Zielonka D
AU  - Del Mar Garcia Romero M
AU  - Ip W
AU  - Stray-Pedersen A
AU  - Børresen ML
AU  - Gomez-Andres D
AU  - Lissauer S
AU  - Pachlopnik-Schmid J
AU  - Karampatsas K
AU  - Wu S
AU  - Pisani F
AU  - Lederman H
AU  - Badolato R
AU  - Kern J
AU  - Kornmann O
AU  - Donath H
AU  - Whitehouse WP
AU  - Koenig MK
AU  - Abolhassani H
AU  - Schaefer C
AU  - Roden M
AU  - Thye D
AU  - Smith A
AU  - Horn B
AU  - Prayle A
PY  - 2026
JO  - The Lancet. Child & adolescent health
DO  - 10.1016/s2352-4642(26)00125-2
UR  - https://doi.org/10.1016/s2352-4642(26)00125-2
ER  - 

APA

S, R., S, Z., B, P., J, T., S, P., D, Z., M, D. M. G. R., W, I., A, S., ML, B., D, G., S, L., J, P., K, K., S, W., F, P., H, L., R, B., J, K., O, K., H, D., WP, W., MK, K., H, A., C, S., M, R., D, T., A, S., B, H., & A, P. (2026). Neurological effects of encapsulated dexamethasone sodium phosphate in children aged 6-9 years with ataxia telangiectasia (NEAT): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.. The Lancet. Child & adolescent health. https://doi.org/10.1016/s2352-4642(26)00125-2

Source records